Titre : Sympatrie

Sympatrie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Clinical Decision-Making
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sympatrie : Questions médicales les plus fréquentes", "headline": "Sympatrie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sympatrie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sympatrie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénomènes génétiques", "url": "https://questionsmedicales.fr/mesh/D055614", "about": { "@type": "MedicalCondition", "name": "Phénomènes génétiques", "code": { "@type": "MedicalCode", "code": "D055614", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05" } } }, "about": { "@type": "MedicalCondition", "name": "Sympatrie", "alternateName": "Sympatry", "code": { "@type": "MedicalCode", "code": "D061350", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Violaine Llaurens", "url": "https://questionsmedicales.fr/author/Violaine%20Llaurens", "affiliation": { "@type": "Organization", "name": "Institut de Systématique, Evolution et Biodiversité, UMR 7205 CNRS/MNHN/Sorbonne Université/EPHE, Museum National d'Histoire Naturelle, Paris, France." } }, { "@type": "Person", "name": "Vincent Debat", "url": "https://questionsmedicales.fr/author/Vincent%20Debat", "affiliation": { "@type": "Organization", "name": "Institut de Systématique, Evolution et Biodiversité, UMR 7205 CNRS/MNHN/Sorbonne Université/EPHE, Museum National d'Histoire Naturelle, Paris, France." } }, { "@type": "Person", "name": "Antonio Frangipane di Regalbono", "url": "https://questionsmedicales.fr/author/Antonio%20Frangipane%20di%20Regalbono", "affiliation": { "@type": "Organization", "name": "Department of Animal Medicine, Production and Health, University of Padova, Padova, Italy." } }, { "@type": "Person", "name": "L Blohm", "url": "https://questionsmedicales.fr/author/L%20Blohm", "affiliation": { "@type": "Organization", "name": "Centro de Medicina Tropical de Oriente, Universidad de Oriente (UDO) Núcleo Anzoátegui, Barcelona, Estado Anzoátegui Venezuela." } }, { "@type": "Person", "name": "J L De Sousa", "url": "https://questionsmedicales.fr/author/J%20L%20De%20Sousa", "affiliation": { "@type": "Organization", "name": "Centro de Medicina Tropical de Oriente, Universidad de Oriente (UDO) Núcleo Anzoátegui, Barcelona, Estado Anzoátegui Venezuela." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Clinical decision making in prostate cancer care-evaluation of EAU-guidelines use and novel decision support software.", "datePublished": "2024-08-18", "url": "https://questionsmedicales.fr/article/39155288", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-70292-y" } }, { "@type": "ScholarlyArticle", "name": "Clinical decision-making on lung cancer investigations in primary care: a vignette study.", "datePublished": "2024-08-21", "url": "https://questionsmedicales.fr/article/39174063", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-082495" } }, { "@type": "ScholarlyArticle", "name": "Improve the efficiency and accuracy of ophthalmologists' clinical decision-making based on AI technology.", "datePublished": "2024-07-09", "url": "https://questionsmedicales.fr/article/38982465", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12911-024-02587-z" } }, { "@type": "ScholarlyArticle", "name": "Restorative dentistry clinical decision-making for hypodontia: managing missing premolar teeth.", "datePublished": "2023-10-13", "url": "https://questionsmedicales.fr/article/37828180", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41415-023-6333-4" } }, { "@type": "ScholarlyArticle", "name": "Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making.", "datePublished": "2023-07-22", "url": "https://questionsmedicales.fr/article/37479967", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-023-11078-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Sympatrie", "item": "https://questionsmedicales.fr/mesh/D061350" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sympatrie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sympatrie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sympatrie", "description": "Comment identifier la sympatrie chez les espèces ?\nQuels outils sont utilisés pour étudier la sympatrie ?\nLa sympatrie peut-elle être observée chez les mammifères ?\nQuels signes indiquent une sympatrie chez les oiseaux ?\nComment la sympatrie est-elle mesurée ?", "url": "https://questionsmedicales.fr/mesh/D061350?mesh_terms=Clinical+Decision-Making&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sympatrie", "description": "Quels symptômes indiquent une compétition en sympatrie ?\nLa sympatrie cause-t-elle des maladies ?\nQuels signes de stress peuvent apparaître en sympatrie ?\nLes espèces en sympatrie montrent-elles des adaptations ?\nComment la sympatrie affecte-t-elle la reproduction ?", "url": "https://questionsmedicales.fr/mesh/D061350?mesh_terms=Clinical+Decision-Making&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sympatrie", "description": "Comment prévenir la perte de sympatrie ?\nQuelles lois protègent la sympatrie ?\nComment sensibiliser à la sympatrie ?\nQuel rôle jouent les ONG dans la sympatrie ?\nComment les citoyens peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D061350?mesh_terms=Clinical+Decision-Making&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sympatrie", "description": "Y a-t-il des traitements pour les espèces en sympatrie ?\nComment gérer la compétition en sympatrie ?\nLes interventions humaines affectent-elles la sympatrie ?\nQuelles sont les stratégies de conservation en sympatrie ?\nComment les zoos contribuent-ils à la sympatrie ?", "url": "https://questionsmedicales.fr/mesh/D061350?mesh_terms=Clinical+Decision-Making&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sympatrie", "description": "Quelles complications peuvent survenir en sympatrie ?\nLa sympatrie entraîne-t-elle des hybridations ?\nQuels impacts sur l'écosystème en sympatrie ?\nComment la sympatrie affecte-t-elle la survie des espèces ?\nLes maladies se propagent-elles en sympatrie ?", "url": "https://questionsmedicales.fr/mesh/D061350?mesh_terms=Clinical+Decision-Making&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sympatrie", "description": "Quels facteurs augmentent la sympatrie ?\nComment le changement climatique affecte-t-il la sympatrie ?\nQuels rôles jouent les prédateurs en sympatrie ?\nLes invasions biologiques affectent-elles la sympatrie ?\nQuel impact a l'urbanisation sur la sympatrie ?", "url": "https://questionsmedicales.fr/mesh/D061350?mesh_terms=Clinical+Decision-Making&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier la sympatrie chez les espèces ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'observation des habitats et des comportements des espèces permet d'identifier la sympatrie." } }, { "@type": "Question", "name": "Quels outils sont utilisés pour étudier la sympatrie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des études génétiques et des analyses de niche écologique sont couramment utilisées." } }, { "@type": "Question", "name": "La sympatrie peut-elle être observée chez les mammifères ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses espèces de mammifères peuvent coexister en sympatrie dans un même habitat." } }, { "@type": "Question", "name": "Quels signes indiquent une sympatrie chez les oiseaux ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'observation de plusieurs espèces d'oiseaux se nourrissant ou nidifiant dans la même zone est un signe." } }, { "@type": "Question", "name": "Comment la sympatrie est-elle mesurée ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle est mesurée par des indices de diversité et des analyses de distribution des espèces." } }, { "@type": "Question", "name": "Quels symptômes indiquent une compétition en sympatrie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution des ressources et des changements de comportement peuvent être observés." } }, { "@type": "Question", "name": "La sympatrie cause-t-elle des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, la sympatrie en elle-même ne cause pas de maladies, mais peut influencer la santé des espèces." } }, { "@type": "Question", "name": "Quels signes de stress peuvent apparaître en sympatrie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements agressifs ou des changements alimentaires peuvent indiquer du stress." } }, { "@type": "Question", "name": "Les espèces en sympatrie montrent-elles des adaptations ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent développer des adaptations morphologiques ou comportementales pour coexister." } }, { "@type": "Question", "name": "Comment la sympatrie affecte-t-elle la reproduction ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des mécanismes de sélection sexuelle pour éviter l'hybridation." } }, { "@type": "Question", "name": "Comment prévenir la perte de sympatrie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La protection des habitats naturels et la régulation des activités humaines sont essentielles." } }, { "@type": "Question", "name": "Quelles lois protègent la sympatrie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des lois sur la conservation de la faune et des habitats protègent les espèces en sympatrie." } }, { "@type": "Question", "name": "Comment sensibiliser à la sympatrie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes éducatives et des programmes de sensibilisation peuvent aider à préserver la biodiversité." } }, { "@type": "Question", "name": "Quel rôle jouent les ONG dans la sympatrie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les ONG œuvrent pour la conservation des espèces et la protection des habitats en sympatrie." } }, { "@type": "Question", "name": "Comment les citoyens peuvent-ils aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les citoyens peuvent participer à des projets de conservation et signaler les espèces menacées." } }, { "@type": "Question", "name": "Y a-t-il des traitements pour les espèces en sympatrie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements visent généralement à gérer les populations et à préserver la biodiversité." } }, { "@type": "Question", "name": "Comment gérer la compétition en sympatrie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des stratégies de conservation et de gestion des habitats peuvent réduire la compétition." } }, { "@type": "Question", "name": "Les interventions humaines affectent-elles la sympatrie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'urbanisation et l'agriculture peuvent perturber les habitats et la sympatrie." } }, { "@type": "Question", "name": "Quelles sont les stratégies de conservation en sympatrie ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La création de réserves naturelles et la restauration des habitats sont des stratégies clés." } }, { "@type": "Question", "name": "Comment les zoos contribuent-ils à la sympatrie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les zoos participent à la conservation des espèces et à l'éducation sur la biodiversité." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir en sympatrie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des conflits interspécifiques et une pression sur les ressources peuvent survenir." } }, { "@type": "Question", "name": "La sympatrie entraîne-t-elle des hybridations ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la sympatrie peut favoriser l'hybridation entre espèces proches, affectant la biodiversité." } }, { "@type": "Question", "name": "Quels impacts sur l'écosystème en sympatrie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La sympatrie peut modifier les dynamiques écologiques et la structure des communautés." } }, { "@type": "Question", "name": "Comment la sympatrie affecte-t-elle la survie des espèces ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La compétition accrue peut réduire les chances de survie de certaines espèces en sympatrie." } }, { "@type": "Question", "name": "Les maladies se propagent-elles en sympatrie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la proximité des espèces peut faciliter la transmission de maladies entre elles." } }, { "@type": "Question", "name": "Quels facteurs augmentent la sympatrie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "La disponibilité des ressources et la diversité des habitats favorisent la sympatrie." } }, { "@type": "Question", "name": "Comment le changement climatique affecte-t-il la sympatrie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le changement climatique peut modifier les habitats et influencer la sympatrie des espèces." } }, { "@type": "Question", "name": "Quels rôles jouent les prédateurs en sympatrie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les prédateurs peuvent influencer la distribution et la coexistence des espèces en sympatrie." } }, { "@type": "Question", "name": "Les invasions biologiques affectent-elles la sympatrie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les espèces envahissantes peuvent perturber les interactions en sympatrie et menacer les espèces natives." } }, { "@type": "Question", "name": "Quel impact a l'urbanisation sur la sympatrie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'urbanisation peut fragmenter les habitats et réduire les opportunités de sympatrie." } } ] } ] }

Sources (10000 au total)

Clinical decision-making on lung cancer investigations in primary care: a vignette study.

To investigate the role of comorbid chronic obstructive pulmonary disease (COPD) and symptom type on general practitioners' (GP's) symptom attribution and clinical decision-making in relation to lung ... Vignette survey with a 2×2 mixed factorial design.... A nationwide online survey exploring clinical decision-making in primary care.... 109 GPs based in the United Kingdom (UK) who were registered as responders on Dynata (an online survey platform).... GPs were presented with four vignettes which described a patient aged 75 with a smoking history presenting with worsening symptoms (either general or respiratory) and with or without a pre-existing di... GPs indicated the three most likely diagnoses (free-text) and selected four management approaches (20 pre-coded options). Attribution of symptoms to lung cancer and referral for urgent chest X-ray wer... 422 vignettes were completed. There was no evidence for COPD status as a predictor of lung cancer attribution (OR=1.1, 95% CI=0.5-2.4, p=0.914). There was no evidence for COPD status as a predictor of... Lung cancer was identified as a possible diagnosis for persistent respiratory by only one out of five GPs, irrespective of the patients' COPD status. Increasing awareness among GPs of the link between...

Improve the efficiency and accuracy of ophthalmologists' clinical decision-making based on AI technology.

As global aging intensifies, the prevalence of ocular fundus diseases continues to rise. In China, the tense doctor-patient ratio poses numerous challenges for the early diagnosis and treatment of ocu... In this study, eight Chinese Named Entity Recognition (NER) models were compared, and the SoftLexicon-Glove-Word2vec model, achieving a high F1 score of 93.02%, was selected as the optimal recognition... The use of the diagnostic intelligent decision support platform resulted in significant improvements in both diagnostic efficiency and accuracy for both experienced and junior doctors (P < 0.05). Nota... The diagnostic intelligent decision support platform established in this study, based on the XGBoost algorithm and NER, effectively enhances the diagnostic efficiency and accuracy of junior doctors in...

Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making.

Despite recent advances in research, there are still critical lacunae in our basic understanding of the cause, pathogenesis, and natural history of many cancers, especially heterogeneity in patient re... Human iPSCs from healthy donors, breast and ovarian cancer patients were successfully differentiated towards isogenic hepatic, cardiac, neural and endothelial lineages. Multicellular organoids were es... Ovarian and breast cancer patients' organoids showed heterogeneity in drug resistance and sensitivity. iPSCs-derived cardiomyocytes, hepatocytes and neurons showed donor-to-donor variability of chemot... We report development of a novel integrated platform to facilitate clinical decision-making using the patient's primary cells, iPSCs and derivatives, to clinically relevant models for oncology researc...

Accelerated approval drug labels often lack information for clinical decision-making.

We evaluated US Food and Drug Administration labels for drugs approved under the accelerated approval pathway and whether these labels contained in sufficient information regarding their accelerated a... Retrospective, observational, cohort study.... Label information for drugs with an accelerated approved indication were ascertained from two online platforms: Drugs@FDA and FDA Drug Label Repository.... Drugs with indications receiving accelerated approval after January 1, 1992, but had not received full approval by December 31, 2020.... Outcomes include whether the drug label indicated the use of the accelerated approval pathway, identified the specific surrogate marker(s) that supported it, or described the clinical outcomes being e... 253 clinical indications corresponding to 146 drugs received accelerated approval. We identified a total of 110 accelerated approval indications across 62 drugs that had not received full approval by ... Labels for accelerated approved clinical indications that do not yet have full approval should be revised to include the information required in the FDA guidance to help guide clinical decision-making...

Clinical decision making in paediatric otitis media: A pilot quality improvement study.

This study aimed to improve local management of paediatric otitis media using the 2022 American-Academy of Otolaryngology Head and Neck Surgery (AAO-HNS) Clinical Practice Guideline for Tympanostomy T... A SQUIRE 2.0 compliant quality improvement study was carried out within the outpatient department of our otolaryngology tertiary referral centre. Local outpatient management of paediatric otitis media... Overall, 88 children were included (46 pre-intervention and 42 post-intervention) with a mean age of 7.6 years (range 1-12 years). Sixty-four (72.7%) children presented with suspected otitis media wit... A focussed educational intervention may improve local adherence to guidelines in the management of paediatric otitis media. Continued re-evaluation of local practice is essential in order to ensure ch...